Obesity is far more complex than previously understood, with dozens of genetic, biological, neurological, and metabolic factors contributing to weight gain. While GLP-1 drugs like Ozempic, Wegovy, Zepbound, and Mounjaro have transformed weight loss treatment for millions, they don't work for everyone. But researchers are using these failures as a roadmap to develop personalized obesity care that targets each person's unique underlying causes. Why Don't GLP-1 Drugs Work for Everyone? A significant portion of people taking GLP-1 medications experience disappointing results. Studies show that while roughly half of patients lose 15% or more of their body weight on these drugs, the other half loses less than 5% of their body weight, though they may still experience metabolic improvements like better blood sugar control. Some patients also struggle with side effects like nausea that make continuing treatment difficult. The reason for these varied outcomes is becoming clearer: obesity itself comes in many different forms. "There are many types of obesity, and each type of obesity has a unique genetic predisposition," said Andres Acosta, a gastroenterologist and hepatologist at the Mayo Clinic. Andres Acosta, Gastroenterologist and Hepatologist at Mayo Clinic Acosta notes that early research indicates genetic markers might predict whether a person will respond well to GLP-1 medicines, suggesting that one-size-fits-all treatment approaches are outdated. What Are the Different Types of Obesity? Researchers are now categorizing obesity into distinct phenotypes, or observable trait patterns, based on genetic and hormonal factors. A cheek-swab genetic test developed by Phenomix Sciences groups people into four basic obesity phenotypes, each with different drivers and treatment implications: - Hungry Gut: People with abnormalities in their gut hormones tend to lose more weight on GLP-1 medicines, as these drugs work by mimicking hormones that regulate appetite and blood sugar. - Hungry Brain: Some individuals have broken neural pathways that prevent GLP-1 drugs from being as effective; for these people, earlier generations of weight-loss medicines or combinations of new and old drugs often work better. - Emotional Hunger: People with emotionally driven eating habits may not benefit as much from GLP-1 drugs alone, as their obesity is driven more by psychological factors than hormonal ones. - Slow Burn: This phenotype involves metabolic factors that may require different treatment approaches than hormone-focused interventions. A person might belong to more than one of these categories, making their obesity profile even more complex. Understanding which category applies to you can help doctors choose the most effective treatment strategy. How to Identify Your Obesity Type for Better Treatment - Genetic Testing: Ask your doctor about cheek-swab genetic tests that can identify your obesity phenotype and any underlying genetic disorders affecting hunger and satiety signals. - Hormone Assessment: Work with an obesity medicine specialist to evaluate your gut hormones and neurological pathways, which can predict how well you'll respond to specific medications. - Lifestyle Factor Review: Discuss emotional eating patterns, stress levels, and behavioral triggers with your healthcare provider to determine if psychological factors are driving your weight gain. - Medication Matching: Once your obesity type is identified, your doctor can recommend the most effective drug or combination of drugs, rather than defaulting to the most popular option. For Anna Olson, a 36-year-old from Minneapolis, genetic testing revealed she has a "Hungry Brain" phenotype and also carries Bardet-Biedl syndrome, a genetic disorder that predisposes people to eat too much. This knowledge was transformative. "Knowing that reduced her sense of stigma and helped her find the most fitting combination of medications for her," according to the source material. She initially tried Ozempic, a GLP-1 drug, but found that Zepbound worked better for her specific hormonal imbalance. Combined with understanding her genetic drivers, she has lost 65 pounds and kept it off, while also improving her cholesterol and blood sugar levels. The chemistry of a person's gut microbiome, their proclivity toward addiction, and the molecular shape of their hormone receptors can all affect how well a drug works. "The medication might be degraded faster in one individual than in another," explained Dr. Lydia Alexander, past president of the Obesity Medicine Association. Dr. Lydia Alexander, Past President of the Obesity Medicine Association This means that even identical medications can have vastly different effects depending on each person's unique biology. What's the Timeline for Personalized Obesity Treatment? More precise diagnosis of specific obesity forms is still a few years away, but researchers are getting closer to understanding the variables that make a difference. Within several years, doctors expect treatment will be customized to meet the needs of each patient, similar to how cancer therapies now target specific tumor subtypes. This shift represents a fundamental change in how obesity is understood and treated, moving away from the outdated advice of simply "eating less" and toward precision medicine. However, experts emphasize that medication alone is never the complete answer. "One tool does not work for each person, and one tool often is not enough over the lifetime of a person to control or to mitigate the health impact of that condition," stated Dr. Jennifer Manne-Goehler, a Harvard metabolic disease specialist. Dr. Jennifer Manne-Goehler, Metabolic Disease Specialist at Harvard A recent review of 37 studies on weight loss found that people who rely on GLP-1 drugs tend to gain back weight at a faster rate when they stop treatment, compared to those who rely on behavioral change. This underscores that lifestyle adaptations remain critical for full and lasting results, even when medications are part of the plan. The takeaway is clear: obesity is not a one-size-fits-all condition, and neither should treatment be. By understanding your specific obesity type, genetic factors, and hormonal drivers, you and your doctor can develop a truly personalized approach that combines the right medication with lifestyle changes tailored to your unique needs.
